The Lymphocytic Infiltrate of Lung Tumors.

Recruiting now

Conditions studied: Lung Cancer, Immune System

In brief

The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.

Key facts

Study ID

NCT06470607

Run by

Scientific Institute San Raffaele

People needed

70

Starts

2023-01-20

Expected to finish

2028-01-31

Last updated by the study team

2024-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to provide informed consent;
• Men and women over the age of 18;
• Patients candidates for surgical treatment diagnosed with thoracic tumors

You may not qualify if…

• Previous chemotherapy for any cancer within the last 6 months;
• Pregnant and/or breastfeeding women;
• Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)

Where it is running

• Scientific Institute Ospedale San Raffaele — Milan, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.